Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

PRJNA604975

ABSTRACT: Whole genome sequencing of Gram-negative bacteremias from Oxfordshire, UK.

PROVIDER: PRJEB37212 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR3986900_1.fastq.gz	Fastqsanger.gz
	ERR3986910_1.fastq.gz	Fastqsanger.gz
	ERR3986920_1.fastq.gz	Fastqsanger.gz
	ERR3986930_1.fastq.gz	Fastqsanger.gz
	ERR3986901_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 46

Similar Datasets

Project description:Gram-negative bacteremias in Oxfordshire

| PRJNA604975 | ENA

De novo assembly of siRNA immunity in wild plants

Project description:We describe an application of deep sequencing and de novo assembly of short RNA reads to investigate small interfering (si)RNAs mediated immunity in leaf samples from eight tree taxa naturally occurring in Wytham Woods, Oxfordshire, UK. BLAST search for homologues of contigs in the GenBank identified siRNA populations against a number of RNA viruses and a Ty1-copia retrotransposons in these tree species.

2012-06-01 | GSE22079 | GEO

De novo assembly of siRNA immunity in wild plants

2012-06-01 | E-GEOD-22079 | biostudies-arrayexpress

Project description:Whole genome sequencing of Gram-negative bacteria

| PRJNA871949 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Project description:Whole-genome sequencing of Gram-negative bacterial strains

| PRJNA1247368 | ENA

Gram negative bacilli

Project description:Gram negative bacilli Genome sequencing

| PRJNA353060 | ENA

Gram negative bacteria

Project description:Gram negative bacteria Genome sequencing

| PRJNA594823 | ENA

Bacteria

Project description:Gram-negative Pathogen Genome Sequencing

| PRJNA261239 | ENA